Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term adenocarcinoma. Found 92 abstracts

no pagination
Berger AC, Winter K, Hoffman JP, Regine WF, Abrams RA, Safran H, Freedman GM, Benson AB, MacDonald J, Willett CG. Five Year Results of US Intergroup/RTOG 9704 With Postoperative CA 19-9 <= 90 U/mL and Comparison to the CONKO-001 Trial. International Journal of Radiation Oncology Biology Physics. 2012 Nov;84(3):E291-E297.
Berger AC, Winter K, Hoffman JP, Regine WF, Abrams RA, Safran H, Freedman GM, Benson AB, MacDonald J, Willett CG. Five Year Results of US Intergroup/RTOG 9704 With Postoperative CA 19-9 <= 90 U/mL and Comparison to the CONKO-001 Trial. International Journal of Radiation Oncology Biology Physics. 2012 Nov;84(3):E291-E297.
Falk GW, Buttar NS, Foster NR, Ziegler KL, Demars CJ, Romero Y, Marcon NE, Schnell T, Corley DA, Sharma P, Cruz-Correa MR, Hur C, Fleischer DE, Chak A, Devault KR, Weinberg DS, Della'Zanna G, Richmond E, Smyrk TC, Mandrekar SJ, Limburg PJ. A Combination of Esomeprazole and Aspirin Reduces Tissue Concentrations of Prostaglandin E-2 in Patients With Barrett's Esophagus. Gastroenterology. 2012 Oct;143(4):917-U91.   PMCID: PMC3458136
Hammerman PS, Lawrence MS, Voet D, Jing R, Cibulskis K, Sivachenko A, Stojanov P, McKenna A, Lander ES, Gabriel S, Getz G, Sougnez C, Imielinski M, Helman E, Hernandez B, Pho NH, Meyerson M, Chu A, Chun HJ, Mungall AJ, Pleasance E, Robertson AG, Sipahimalani P, Stoll D, Balasundaram M, Birol I, Butterfield YS, Chuah E, Coope RJ, Corbett R, Dhalla N, Guin R, Hirst AC, Hirst M, Holt RA, Lee D, Li HI, Mayo M, Moore RA, Mungall K, Nip KM, Olshen A, Schein JE, Slobodan JR, Tam A, Thiessen N, Varhol R, Zeng T, Zhao Y, Jones SJ, Marra MA, Saksena G, Cherniack AD, Schumacher SE, Tabak B, Carter SL, Nguyen H, Onofrio RC, Crenshaw A, Ardlie K, Beroukhim R, Winckler W, Protopopov A, Zhang JH, Hadjipanayis A, Lee S, Xi RB, Yang LX, Ren XJ, Zhang HL, Shukla S, Chen PC, Haseley P, Lee E, Chin L, Park PJ, Kucherlapati R, Socci ND, Liang YP, Schultz N, Borsu L, Lash AE, Viale A, Sander C, Ladanyi M, Auman JT, Hoadley KA, Wilkerson MD, Shi Y, Liquori C, Meng SW, Li L, Turman YJ, Topal MD, Tan DH, Waring S, Buda E, Walsh J, Jones CD, Mieczkowski PA, Singh D, Wu J, Gulabani A, Dolina P, Bodenheimer T, Hoyle AP, Simons JV, Soloway MG, Mose LE, Jefferys SR, Balu S, O'Connor BD, Prins JF, Liu J, Chiang DY, Hayes DN, Perou CM, Cope L, Danilova L, Weisenberger DJ, Maglinte DT, Pan F, den Berg DJ, Triche T, Herman JG, Baylin SB, Laird PW, Noble M, Gehlenborg N, DiCara D, Wu CJ, Liu SY, Zou LH, Lin P, Cho J, Nazaire MD, Robinson J, Thorvaldsdottir H, Mesirov J, Sinha R, Ciriello G, Cerami E, Gross B, Jacobsen A, Gao J, Aksoy BA, Weinhold N, Ramirez R, Taylor BS, Antipin Y, Reva B, Shen RL, Mo Q, Seshan V, Paik PK, Akbani R, Zhang NX, Broom BM, Casasent T, Unruh A, Wakefield C, Cason RC, Baggerly KA, Weinstein JN, Haussler D, Benz CC, Stuart JM, Zhu JC, Szeto C, Scott GK, Yau C, Ng S, Goldstein T, Waltman P, Sokolov A, Ellrott K, Collisson EA, Zerbino D, Wilks C, Ma S, Craft B, Du Y, Cabanski C, Walter V, Wu JY, Marron JS, Liu Y, Wang K, Creighton CJ, Zhang YQ, Travis WD, Rekhtman N, Yi J, Aubry MC, Cheney R, Dacic S, Flieder D, Funkhouser W, Illei P, Myers J, Tsao MS, Penny R, Mallery D, Shelton T, Hatfield M, Morris S, Yena P, Shelton C, Sherman M, Paulauskis J, Govindan R, Azodo I, Beer D, Bose R, Byers LA, Carbone D, Chang LW, Chiang D, Chun E, Collisson E, Ding L, Heymach J, Ida C, Johnson B, Jurisica I, Kaufman J, Kosari F, Kwiatkowski D, Maher CA, Mungall A, Pao W, Peifer M, Robertson G, Rusch V, Siegfried J, Stuart J, Thomas RK, Tomaszek S, Vaske C, Weisenberger D, Wheeler D, Wigle DA, Yang P, Zhang JJ, Jensen MA, Sfeir R, Kahn AB, Chu AL, Kothiyal P, Wang Z, Snyder EE, Pontius J, Pihl TD, Ayala B, Backus M, Walton J, Baboud J, Berton DL, Nicholls MC, Srinivasan D, Raman R, Girshik S, Kigonya PA, Alonso S, Sanbhadti RN, Barletta SP, Greene JM, Pot DA, Bandarchi-Chamkhaleh B, Boyd J, Weaver J, Azodo IA, Tomaszek SC, Ida CM, Brock MV, Rogers K, Rutledge M, Brown T, Lee B, Shin J, Trusty D, Dhir R, Siegfried JM, Potapova O, Fedosenko KV, Nemirovich-Danchenko E, Zakowski M, Iacocca MV, Brown J, Rabeno B, Czerwinski C, Petrelli N, Fan Z, Todaro N, Eckman J, Rathmell WK, Thorne LB, Huang M, Boice L, Hill A, Curley E, Morrison C, Gaudioso C, Bartlett JS, Kodeeswaran S, Zanke B, Sekhon H, David K, Juhl H, Van Le X, Kohl B, Thorp R, Tien NV, Van Bang N, Sussman H, Phu BD, Hajek R, PhiHung N, Khan KZ, Muley T, Shaw KR, Sheth M, Yang L, Buetow K, Davidsen T, Demchok JA, Eley G, Ferguson M, Dillon LA, Schaefer C, Guyer MS, Ozenberger BA, Palchik JD, Peterson J, Sofia HJ, Thomson E. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep;489(7417):519-25.   PMCID: PMC3466113
Kimbrell HZ, Gustafson KS, Huang M, Ehya H. Subclassification of Non-Small Cell Lung Cancer by Cytologic Sampling: A Logical Approach with Selective Use of Immunocytochemistry. Acta Cytologica. 2012 Jan;56(4):419-24.
Gulec SA, Cohen SJ, Pennington KL, Zuckier LS, Hauke RJ, Horne H, Wegener WA, Teoh N, Gold DV, Sharkey RM, Goldenberg DM. Treatment of Advanced Pancreatic Carcinoma with Y-90-Clivatuzumab Tetraxetan: A Phase I Single-Dose Escalation Trial. Clinical Cancer Research. 2011 Jun;17(12):4091-100.   PMCID: not NIH funded
Gumbs AA, Rivera AM, Milone L, Hoffman JP. Laparoscopic Pancreatoduodenectomy: A Review of 285 Published Cases. Annals of Surgical Oncology. 2011 May;18(5):1335-41.   PMCID: not NIH funded
Chun YS, Milestone BN, Watson JC, Cohen SJ, Burtness B, Engstrom PF, Haluszka O, Tokar JL, Hall MJ, Denlinger CS, Astsaturov I, Hoffman JP. Defining Venous Involvement in Borderline Resectable Pancreatic Cancer. Annals of Surgical Oncology. 2010 Nov;17(11):2832-8.   PMCID: no NIH funding
Hoffman JP. Status of Neoadjuvant Therapy for Resectable Pancreatic Cancer. Surgical Oncology Clinics of North America. 2010 Apr;19(2):411-+.   PMCID: not NIH funded
Rajput A, Romanus D, Weiser MR, Ter Veer A, Niland J, Wilson J, Skibber JM, Wong YN, Benson A, Earle CC, Schrag D. Meeting the 12 Lymph Node (LN) Benchmark in Colon Cancer. Journal of surgical oncology. 2010 Jul;102(1):3-9.   PMCID: not NIH funded
Showalter SL, Rosato EL, Anne PR, Scott W, Mitchell E, Berger AC. Does Diabetes Mellitus Influence Pathologic Complete Response and Tumor Downstaging After Neoadjuvant Chemoradiation for Esophageal and Gastroesophageal Cancer? A Two-Institution Report. Journal of surgical oncology. 2010 Jan;101(1):43-6.   PMCID: not NIH funded
Tempero MA, Arnoletti JP, Behrman S, Ben-Josef E, Benson AB, Berlin JD, Cameron JL, Casper ES, Cohen SJ, Duff M, Ellenhorn JD, Hawkins WG, Hoffman JP, Kuvshinoff BW, Malafa MP, Muscarella P, Nakakura EK, Sasson AR, Thayer SP, Tyler DS. Pancreatic Adenocarcinoma. Journal of the National Comprehensive Cancer Network. 2010 Sep;8(9):972-+.   PMCID: PMC3135380
Engstrom PF, Arnoletti JP, Benson AB, Chen YJ, Choti MA, Cooper HS, Covey A, Dilawari RA, Early DS, Enzinger PC, Fakih MG, Fleshman J, Fuchs C, Grem JL, Kiel K, Knol JA, Leong LA, Lin E, Mulcahy MF, Rao S, Ryan DP, Saltz L, Shibata D, Skibber JM, Sofocleous C, Thomas J, Venook AP, Willett C. Colon Cancer. Journal of the National Comprehensive Cancer Network. 2009 Sep;7(8):778-831.   PMCID: no NIH - Practice Guideline
Mabuchi S, Kawase C, Altomare DA, Morishige K, Sawada K, Hayashi M, Tsujimoto M, Yamoto M, Klein-Szanto AJ, Schilder RJ, Ohmichi M, Testa JR, Kimura T. mTOR Is a Promising Therapeutic Target Both in Cisplatin-Sensitive and Cisplatin-Resistant Clear Cell Carcinoma of the Ovary. Clinical Cancer Research. 2009 Sep;15(17):5404-13.   PMCID: PMC2743856
Carter D, Vazquez M, Flieder DB, Brambilla E, Gazdar A, Noguchi M, Travis WD, Kramer A, Yip R, Yankelevitz DF, Henschke CI. Comparison of pathologic findings of baseline and annual repeat cancers diagnosed on CT screening. Lung Cancer. 2007 May;56(2):193-9.
Flieder DB, Vazque M, Carter D, Brambilla E, Gazdar A, Noguchi M, Travis WD, Kramer A, Yankelevitz DF, Heimschke CI. Pathologic findings of lung tumors diagnosed on baseline CT screening. AMERICAN JOURNAL OF SURGICAL PATHOLOGY. 2006 May;30(5):606-13.
Henry LR, Goldberg M, Scott W, Konski A, Meropol NJ, Freedman G, Weiner LM, Watts P, Beard M, McLaughlin S, Cheng JD. Induction cisplatin and paclitaxel followed by combination chemoradiotherapy with 5-fluorouracil, cisplatin, and paclitaxel before resection in localized esophageal cancer: A phase II report. ANNALS OF SURGICAL ONCOLOGY. 2006 Feb;13(2):214-20.
Hoffman J. Does prior adjuvant chemoradiotherapy lead to a safer pancreatoduodenectomy?. ANNALS OF SURGICAL ONCOLOGY. 2006 Jan;13(1):7-9.
Ibrahim S, Langer CJ. Successful coronary artery bypass grafting after concurrent chemoradiation therapy in a patient with non-small-cell lung cancer: Case report and review of the literature. Clinical lung cancer. 2006 Nov;8(3):217-9.
Travis WD, Garg K, Franklin WA, Wistuba, Sabloff B, Noguchi M, Kakinuma R, Zakowski M, Ginsberg M, Padera R, Jacobson F, Johnson BE, Hirsch F, Brambilla E, Flieder DB, Geisinger KR, Thunnissen F, Kerr K, Yankelevitz D, Franks TJ, Galvin JR, Henderson DW, Nicholson AG, Hasleton PS, Roggli V, Tsao MS, Cappuzzo F, Vazquez M. Bronchioloalveolar carcinoma and lung adenocarcinoma: The clinical importance and research relevance of the 2004 World Health Organization pathologic criteria. Journal of Thoracic Oncology. 2006 Nov;1(9):S13-S19.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term adenocarcinoma

adenocarcinoma carcinoma survival chemotherapy gemcitabine chemoradiation surgery cancer lung cancer radiotherapy phase-iii trial therapy pathology bronchioloalveolar carcinoma Surgery long-term survival serum randomized-trial randomized controlled-trial ca-19-9 screening preoperative chemoradiation classification resectable pancreatic-cancer risk prognosis NCCN Clinical Practice Guidelines curative resection Oncology non-hodgkins-lymphoma neoplasm recurrence colonic neoplasms adjuvant chemotherapy mutations radiology progression controlled-trial copy-number alteration complications radiosensitization induction gastroesophageal cancer pancreatic-cancer resection specimens chemoradiotherapy fluorouracil plus leucovorin akt bile-duct project esophageal cancer apoptosis lymph-node micrometastases ACTION PROJECT postoperative spiral computed-tomography gene vascular resection extended retroperitoneal lymphadenectomy PERIPHERAL fusion immunohistochemical markers colon cancer rectal-cancer ultrasonography COMPUTED-TOMOGRAPHY pylorus-preserving pancreaticoduodenectomy reconstruction acid experience preoperative biliary drainage 5-fluorouracil number CT mediastinal fibrosis gastric cardia NCCN Guidelines postoperative chemoradiation ttf-1 p63 pathway oxaliplatin-based SURVIVAL pancreaticoduodenectomy CANCER rapamycin colorectal-carcinoma high-dose ursodeoxycholic toxicity Neoadjuvant therapy monoclonal-antibody pam4 induced 1975 cock sj-biometrics-v31-p103 GROUND-GLASS OPACITY radiation-therapy Pathology phase-ii trial PROGNOSTIC-SIGNIFICANCE radioimmunotherapy diabetes mellitus amplification mortality cancer-cells malignant disease ductal carcinoma endoscopic retrograde mammalian target Resectable pancreatic adenocarcinoma therapeutic target in-hospital mortality HIGH-RESOLUTION CT metaanalysis differential-diagnosis oxaliplatin dose rate cell-proliferation dosimetry in-vitro ratio duodenopancreatectomy small adenocarcinoma GENE growth-factor receptor gefitinib CARCINOMA margin status cooperative-oncology-group full-dose gemcitabine expert consensus statement irinotecan concurrent radiation colorectal ADENOCARCINOMA neoadjuvant lymph nodes neoadjuvant chemoradiation outcomes unresectable liver metastases bevacizumab gynecologic-oncology-group resection portal-vein confluence cyclooxygenase-2 combined-modality therapy pancreas randomized Adenosquamous carcinoma Adenocarcinoma-Cytology-Fine needle aspiration-Immunocytochemistry-Large cell carcinoma-Non-small cell lung cancer-Squamous cell carcinoma COUNTY neoadjuvant chemoradiotherapy cholangiopancreatography
Last updated on Friday, January 03, 2020